Related references
Note: Only part of the references are listed.Complication Rates Associated With Pacemaker or Implantable Cardioverter-Defibrillator Generator Replacements and Upgrade Procedures Results From the REPLACE Registry
Jeanne E. Poole et al.
CIRCULATION (2010)
Cardiac-Resynchronization Therapy for Mild-to-Moderate Heart Failure.
Anthony S. L. Tang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Maximizing Survival Benefit With Primary Prevention Implantable Cardioverter-Defibrillator Therapy in a Heart Failure Population
Wayne C. Levy et al.
CIRCULATION (2009)
Impact of Implantable Cardioverter-Defibrillator, Amiodarone, and Placebo on the Mode of Death in Stable Patients With Heart Failure Analysis From the Sudden Cardiac Death in Heart Failure Trial
Douglas L. Packer et al.
CIRCULATION (2009)
Cardiac-Resynchronization Therapy for the Prevention of Heart-Failure Events.
Arthur J. Moss et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Patients with heart failure who require an implantable defibrillator should have cardiac resynchronisation routinely
John G. F. Cleland et al.
HEART (2008)
ACC/AHA/HRS 2008 guidelines for device-ased therapy of cardiac rhythm abnormalities: Executive summary
Sidney C. Smith et al.
HEART RHYTHM (2008)
The effect of cardiac resynchronization on morbidity and mortality in heart failure
JGF Cleland et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Development of indications for cardiac resynchronisation therapy in the implantable cardioverter defibrillator population
JR Paisey et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2005)
Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure
GH Bardy et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Analysis of mortality events in the multicenter automatic defibriflator implantation trial (NLADIT-II)
H Greenberg et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2004)
Share Paper
